Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s13300-021-01119-6
Published Online: 2021-07-27
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Radellini, Stefano
Vigneri, Enrica
Guarnotta, Valentina
Panto, Felicia
Giordano, Carla http://orcid.org/0000-0003-1731-9395
Text and Data Mining valid from 2021-07-27
Version of Record valid from 2021-07-27
Article History
First Online: 27 July 2021